Aspira Women’s Health Announces Appointment of Ellen Beausang to the Board of Directors

By carla | February 11, 2025

AUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (NASDAQ:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Ellen Beausang to the Board of Directors, effective February 10, 2025. “We are pleased to welcome Ellen Beausang to…

Read More